Assessing risk factors is key to implementing the new ICH Q3D guidelines for elemental impurities.
John Glennon
Advertisement
John Glennon is a stability laboratory team leader, GlaxoSmithKline
Articles by John Glennon
Advertisement
Latest Updated Articles
Implementation of ICH Q3D Elemental Impurities Guideline: Challenges and OpportunitiesPublished: March 2nd 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
Challenges for the Global Manufacturing of Vaccines
4
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
5
